title: Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population.
abstract: OBJECTIVE
  Genetic variants of the lipoprotein lipase gene have been associated with dyslipidemia and coronary artery disease. However, data have been inconsistent and are mainly based on selected predominantly male patient groups.
  
  
  METHODS
  We evaluated the influence of the HindIII restriction fragment length polymorphism on lipid levels in the general population (1361 participants of a large population-based survey from Augsburg, Germany; 50% women) as well as the association of this polymorphism with the risk of myocardial infarction (MI; genotype frequencies in 1159 patients with documented MI under 60 years of age).
  
  
  RESULTS
  In the population-based survey, a highly significant association between the frequent H2H2 genotype and unfavorable cholesterol subfraction levels was observed in men and in postmenopausal women whereas no significant association was observed in premenopausal women (uni- and multivariate analysis). Such unfavorable lipid levels in homozygotes for the H2 allele may be expected to be associated with a 19-25% increased risk to suffer from myocardial infarction (MI). Nevertheless, genotype and allele frequencies in the general population were not different from those in patients with previous MI (H2H2 genotype frequency 51.3% vs. 53.2%, respectively; P=0.63).
  
  
  CONCLUSIONS
  This large study shows that the H2H2 genotype of the lipoprotein lipase gene polymorphism is associated with unfavorable lipid levels. Estrogen status may modulate this association in women. The effects of the genotype on lipid levels were apparently not strong enough to reveal a significant association with MI.
authors.affiliation: Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Franz-Josef-Strauss-Allee 11, D 93042 Regensburg, Germany. stephan.holmer@klinik.uni-regensburg.de
authors.forename: S R
authors.initials: SR
authors.lastname: Holmer
authors.forename: C
authors.initials: C
authors.lastname: Hengstenberg
authors.forename: B
authors.initials: B
authors.lastname: Mayer
authors.forename: A
authors.initials: A
authors.lastname: Döring
authors.forename: H
authors.initials: H
authors.lastname: Löwel
authors.forename: S
authors.initials: S
authors.lastname: Engel
authors.forename: H W
authors.initials: HW
authors.lastname: Hense
authors.forename: M
authors.initials: M
authors.lastname: Wolf
authors.forename: G
authors.initials: G
authors.lastname: Klein
authors.forename: G A
authors.initials: GA
authors.lastname: Riegger
authors.forename: H
authors.initials: H
authors.lastname: Schunkert
mesh_terms: D000328:Adult; D000483:Alleles; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004967:Estrogens / Q000097:blood; D005260:Female; D005838:Genotype; D006306:Health Surveys; D006720:Homozygote; D006801:Humans; D008071:Lipoprotein Lipase / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length; D012044:Regression Analysis; D018570:Risk Assessment
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D004967:Estrogens; D002784:Cholesterol; D008071:Lipoprotein Lipase